Skip to content
Recall Observatory FDA recall evidence

Drug product

Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98), b) 14-count bottles (NDC 0378-5264-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.

D-0443-2017

December 20, 2016

Class II

Product summary

Firm
Mylan LLC.
Event
Event 76020
Status
Terminated
Classification
Class II
Quantity
a) 300 bottles (lot 2006915); b) 156 bottles (lot 2006914)
Official record key
drug-enforcement:D-0443-2017

Official wording

Reason: Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.

Code information: LOT #: a) 2006915, Exp 02/18; b) 2006914, Exp 02/18

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.